SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login
  • Immunotherapy Combination May Benefit Patients with Transplanted Kidneys and Advanced Skin Cancers

    Immunotherapy Combination May Benefit Patients with Transplanted Kidneys and Advanced Skin Cancers

    People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target skin cancers while preserving the transplanted organs.

     READ HERE
    SEE ALL NEWS
    Recent Posts
    Colon Cancer Screening: What You Need to Know Detecting Early-Stage Cancers with a New Blood Test Measuring Epigenetic Instability Oral Bacterium May Promote Breast Cancer Development and Spread Extra Copies of Chromosome 1q May Drive Pancreatic Cancer How Bacteria May Promote Breast Cancer Growth of Spreading Pancreatic Cancer Fueled By “Under-Appreciated” Epigenetic Changes Updated Guidelines Standardize How Tumor Response Is Measured After Surgery Running the Distance: Patient Teams with Johns Hopkins Medicine Dermatologists to Treat, Understand Rare Hereditary Cancer Syndrome New Technology: MRI-guided Focused Ultrasound for Prostate Cancer
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top